Assessing Silicon Labs (SLAB) Valuation After Strong Multi Period Share Price Gains

Silicon Laboratories stock: recent performance snapshot

Silicon Laboratories (SLAB) continues to sit in focus after a strong year to date share price move, with the stock last closing at US$218.27 and showing positive returns over the past month and past 3 months.

See our latest analysis for Silicon Laboratories.

The recent share price momentum, including the 4.37% 1 month share price return and 65.44% year to date share price return, sits alongside a 104.55% 1 year total shareholder return. This combination points to strong short term and multi year performance.

If you are looking for other fast moving opportunities in related areas, this is a good moment to check out 38 AI infrastructure stocks.

With Silicon Laboratories trading near its analyst price target and showing strong recent returns, the key question for you is simple: is this stock still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 2.1% Undervalued

On the most followed narrative, Silicon Laboratories' fair value of $222.86 sits slightly above the last close at $218.27, so the gap is narrow but meaningful for valuation debates.

Rapid expansion of smart home, healthcare, and industrial IoT deployments, including multiple large scale customer production ramps and a deep design win pipeline, supports robust, multi year revenue growth as the number of connected devices in these sectors accelerates. Ongoing rollout of new, highly integrated, energy efficient wireless platforms positions Silicon Labs to capture increased market share and supports higher ASPs, which is likely to drive top line growth and gross margin improvement.

Read the complete narrative.

Want to see what this IoT rollout really assumes? The narrative leans on faster revenue expansion, margin rebuild, and a future earnings multiple that has to carry a lot of weight.

Result: Fair Value of $222.86 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also need to keep an eye on intensifying IoT chip competition and any slowdown in IoT adoption, both of which could affect margins and growth assumptions.

Find out about the key risks to this Silicon Laboratories narrative.

Another angle: what the market multiple is saying

The narrative points to a small 2.1% gap between the fair value of $222.86 and the current $218.27, which frames Silicon Laboratories as slightly undervalued. Yet on a P/S of 9.2x versus 8.1x for the US Semiconductor industry and 7.9x for peers, the stock screens as expensive.

The fair ratio for Silicon Laboratories is 9.4x, only a touch above today’s 9.2x. As a result, the current price already sits close to where the market could reasonably migrate. With that kind of tight spread, are you really being paid for the execution and merger risks you are taking on?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment clearly mixed between recent share price strength and questions about valuation, this is an opportunity to review the investment case and assess the data for yourself, starting with 1 key reward and 1 important warning sign.

Looking for more investment ideas?

If Silicon Laboratories has caught your attention, do not stop here. Use this momentum to size up other opportunities that could fit your portfolio.

• Target potential mispricings by scanning 51 high quality undervalued stocks that combine solid fundamentals with room for a re rating.
• Strengthen your income stream by reviewing 13 dividend fortresses that aim to balance yield with resilience.
• Prioritise balance sheet quality by assessing solid balance sheet and fundamentals stocks screener (45 results) that can better withstand shocks and fund future growth.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com